Ryan McLaughlin, Ph.D

From Seed to Synapse: Modeling the Long-Term
Impacts of Developmental Cannabis Exposure

March 14, 2024, 1 PM MST

Dr. Ryan McLaughlin is an Associate Professor in the Department of Integrative Physiology and Neuroscience at Washington State University (WSU). The overarching goal of Dr. McLaughlin’s research program is to determine how endogenous and exogenous cannabinoids affect the brain and behavior. His research has shown that the endocannabinoid system is a vital component of the neuroendocrine and behavioral response to stress, and that pharmacological targeting of this system can be a promising therapeutic strategy for treating stress-related dysfunction. Dr. McLaughlin is a recipient of the Healthy Minds Canada Prize in Children’s Mental Health and his research team is currently funded by federal grants from the National Institute on Drug Abuse (NIDA) and the National Institute of Mental Health (NIMH). He has over 45 peer-reviewed publications in nationally recognized scientific journals, including Biological Psychiatry, Proceedings of the National Academy of Sciences, Journal of Neuroscience, Neuropsychopharmacology, and Pain, and has authored several book chapters detailing the role of the endocannabinoid system in the regulation of stress and emotional behavior. His research has been covered in various news media outlets, including Forbes, Scientific American, The Scientist, The Seattle Times, and The Washington Post.

Previous Webinars

Suman Chandra, MPhil, PhD.

18 September 2024, 11:AM MST

Cannabis: An Old Plant with New Horizons, Botany and Biomass Production for the Drug Development

Dr. Chandra earned his M.Phil. degree in Environmental Plant Physiology and his Ph.D. in Plant Physiology from The High Altitude Plant Physiology Research Center, HNB Garhwal University (A Central University), India. From 1992 to 2000, […]

Read More »

Carrie Cuttler, PHD.

12 September 2024, 1:00PM MST

Chronic and Acute Effects of High Potency Cannabis Flower and Concentrates on Cognition

Dr. Carrie Cuttler received her Ph.D. in Psychology at the University of British Columbia (UBC) and subsequently conducted a post-doctoral fellowship in the Department of Psychiatry at UBC. She is currently an Associate Professor and Director of […]

Read More »

Dmitry Kurouski, PhD

Raman spectroscopy-assisted diagnosis of cannabis physiological differences

Dmitry Kurouski earned his MS in Biochemistry from Belarusian State University, Belarus and PhD (Distinguished Dissertation) in Analytical Chemistry from SUNY Albany, NY, USA. After a Postdoc in the laboratory of Professor Richard P. Van Duyne at Northwestern University, Dr Kurouski joined BoehringerIngelheim Pharmaceuticals, where he worked […]

Read More »

Elise Weerts, Ph.D.

Interactions of Delta-9 Tetrahydrocannabinol

July 11, 2024, 1:00 PM

Dr. Weerts is a Professor in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine, and core faculty in the preclinical Division of Behavioral Biology (DBB) the Behavioral Pharmacology Research Unit (BPRU) for human clinical and laboratory research.  She has […]

Read More »

Felipe Sarmiento Salazar, PhD

Flowering modulation in Cannabis sp. by night
interruption

June 19, 2024 11:00AM MT

Dr. Felipe Sarmiento Salazar is a biologist graduated from the Universidad de los Andes, doctor in Biology from the University of Freiburg and professor at the Department of Biology of the National University of Colombia since 2016. Professor Sarmiento has extensive experience in […]

Read More »

Ken Olejar, PhD

Cannabinoid extraction and modification: Current and future trends

May 15th, 11:00 AM MST

Dr Ken Olejar is a Research Associate at Colorado State University – Pueblo and the founder of AgriBioactive Consulting. He obtained his MSc in Pharmaceutical Science from the University of Florida and his PhD in Analytical Chemistry from The University of Auckland, New […]

Read More »